Recherche
-
Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques
(Nature Communications. vol. 12, n° 1, pp. 5215, 2021-09-01)Article de revueLibre accès -
New Insights in Microbial Species Predicting Lung Function Decline in CF: Lessons from the MucoFong Project
(Journal of Clinical Medicine. vol. 10, n° 16, 2021-08-21)Article de revueLibre accès -
Estimating the population effectiveness of interventions against COVID-19 in France: A modelling study
(Epidemics. vol. 46, pp. 100744, 2024-03-01)Article de revueLibre accès -
Prediction of long-term humoral response induced by the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola
(NPJ vaccines. vol. 8, n° 1, pp. 174, 2023-11-08)Article de revueLibre accès -
Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection
(eLife. vol. 11, pp. e75427, 2022-07-08)Article de revueLibre accès -
Barrier Gesture Relaxation during Vaccination Campaign in France: Modelling Impact of Waning Immunity
(COVID. vol. 1, n° 2, pp. 472-488, 2021-10-09)Article de revueLibre accès -
A randomized placebo-controlled efficacy study of a prime boost therapeutic vaccination strategy in HIV-1 infected individuals: VRI02 ANRS 149 LIGHT Phase II trial
(Journal of Virology, 2021-02-10)Article de revueLibre accès -
The respiratory microbiota alpha-diversity in chronic lung diseases: first systematic review and meta-analysis
(Respiratory Research. vol. 23, n° 1, pp. 214, 2022-08-23)Article de revueLibre accès -
Impact of non-pharmaceutical interventions, weather, vaccination, and variants on COVID-19 transmission across departments in France: a modelling study
Document de travail - Pré-publicationLibre accès -
Exogenous acquisition of Pseudomonas aeruginosa in intensive care units: a prospective multicentre study, DYNAPYO study
(The Journal of hospital infection. vol. 104, n° 1, pp. 40-45, 2020)Article de revue